Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
5 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Influence of treatments in multiple sclerosis disability: a cohort study.
Mult Scler. 2015 Apr;21(4):433-41. doi: 10.1177/1352458514546788. Epub 2014 Sep 25.
Mult Scler. 2015.
PMID: 25257611
Mitoxantrone treatment in patients with early relapsing-remitting multiple sclerosis.
Cocco E, Marchi P, Sardu C, Russo P, Paolillo A, Mascia M, Solla M, Frau J, Lorefice L, Massole S, Floris G, Marrosu M.
Cocco E, et al. Among authors: massole s.
Mult Scler. 2007 Sep;13(8):975-80. doi: 10.1177/1352458507077621. Epub 2007 Apr 27.
Mult Scler. 2007.
PMID: 17468439
Clinical Trial.
Item in Clipboard
Walking improvements with nabiximols in patients with multiple sclerosis.
Coghe G, Pau M, Corona F, Frau J, Lorefice L, Fenu G, Spinicci G, Mamusa E, Musu L, Massole S, Massa R, Marrosu MG, Cocco E.
Coghe G, et al. Among authors: massole s.
J Neurol. 2015 Nov;262(11):2472-7. doi: 10.1007/s00415-015-7866-5. Epub 2015 Aug 5.
J Neurol. 2015.
PMID: 26239223
Item in Clipboard
Genetic factors and the founder effect explain familial MS in Sardinia.
Marrosu MG, Lai M, Cocco E, Loi V, Spinicci G, Pischedda MP, Massole S, Marrosu G, Contu P.
Marrosu MG, et al. Among authors: massole s.
Neurology. 2002 Jan 22;58(2):283-8. doi: 10.1212/wnl.58.2.283.
Neurology. 2002.
PMID: 11805258
Item in Clipboard
Natalizumab plus interferon beta-1a reduces lesion formation in relapsing multiple sclerosis.
Radue EW, Stuart WH, Calabresi PA, Confavreux C, Galetta SL, Rudick RA, Lublin FD, Weinstock-Guttman B, Wynn DR, Fisher E, Papadopoulou A, Lynn F, Panzara MA, Sandrock AW; SENTINEL Investigators.
Radue EW, et al.
J Neurol Sci. 2010 May 15;292(1-2):28-35. doi: 10.1016/j.jns.2010.02.012. Epub 2010 Mar 16.
J Neurol Sci. 2010.
PMID: 20236661
Clinical Trial.
Item in Clipboard
Cite
Cite